Atossa Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.06 | -$0.06 | -$0.06 |
Q2 2024 | 2 | -$0.06 | -$0.05 | -$0.06 |
Q3 2024 | 0 | -$0.07 | -$0.07 | -$0.07 |
Q1 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q2 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q3 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q4 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
Atossa Therapeutics, Inc. Earnings Date And Information
Atossa Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.05 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Atossa Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.24 diluted earnings per share) and currently has a price-to-earnings ratio of -7.33. Atossa Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Atossa Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/12/2024 | Q2 2024 | -$0.05 | -$0.05 | 0 | $0 | $0 |
05/13/2024 | Q1 2024 | -$0.07 | -$0.05 | 0.02 | $0 | |
04/01/2024 | Q4 2023 | -$0.05 | -$0.06 | -0.01 | $18,000 | |
11/13/2023 | Q3 2023 | -$0.07 | -$0.05 | 0.02 | $0 | |
08/14/2023 | Q2 2023 | -$0.06 | -$0.08 | -0.02 | $0 | |
05/15/2023 | Q1 2023 | -$0.06 | -$0.04 | 0.02 | $0 | |
03/22/2023 | Q4 2022 | $0.06 | -$0.05 | -0.11 | $0 | |
11/07/2022 | Q3 2022 | -$0.06 | -$0.06 | -0 | $0 | |
08/08/2022 | Q2 2022 | -$0.06 | -$0.05 | 0.01 | $0 | |
05/09/2022 | Q1 2022 | -$0.05 | -$0.04 | 0.01 | $0 | |
02/28/2022 | Q4 2021 | -$0.04 | -$0.04 | -0 | $0 | |
11/15/2021 | Q3 2021 | -$0.04 | -$0.04 | -0.01 | $0 | |
08/13/2021 | Q2 2021 | -$0.04 | -$0.06 | -0.02 | $0 | |
05/14/2021 | Q1 2021 | -$0.05 | -$0.04 | 0.01 | $0 | |
03/31/2021 | Q4 2020 | -$0.08 | $0 | |||
11/13/2020 | Q3 2020 | -$0.34 | -$0.34 | 0 | $0 | |
08/13/2020 | Q2 2020 | -$0.28 | -$0.43 | -0.15 | $0 | |
05/13/2020 | Q1 2020 | -$0.39 | -$0.32 | 0.07 | $0 | |
03/26/2020 | Q4 2019 | -$0.33 | -$0.29 | 0.04 | $0 | |
11/13/2019 | Q3 2019 | -$0.52 | -$0.36 | 0.16 | $0 |
Atossa Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Atossa Therapeutics, Inc.'s earnings date?
Atossa Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Atossa Therapeutics, Inc.'s earnings conference call?
The conference call for Atossa Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Atossa Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Atossa Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Atossa Therapeutics, Inc. generate each year?
Atossa Therapeutics, Inc. (:ATOS) has a recorded net income of $0. Atossa Therapeutics, Inc. has generated $-0.24 earnings per share over the last four quarters.
-
What is Atossa Therapeutics, Inc.'s price-to-earnings ratio?
Atossa Therapeutics, Inc. (:ATOS) has a price-to-earnings ratio of -7.33 and price/earnings-to-growth ratio is 0.51.